| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6120283 | Journal of Clinical Virology | 2015 | 6 Pages |
Abstract
NI use in our population is increasing, but early use is not. NI use resulted in no reduction in complications of illness. Resolution of symptoms and reduction in severity of some symptoms were slightly better in adults who were treated early. These modest benefits do not support routine treatment with NI in otherwise healthy individuals with influenza.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Mary P. Fairchok, Wei-Ju Chen, John C. Arnold, Christina Schofield, Patrick J. Danaher, Erin A. McDonough, Martin Ottolini, Deepika Mor, Michelande Ridore, Timothy H. Burgess, Eugene V. Millar,